MindFreedom Battles Eli Lilly over Zyprexa Memos
MindFreedom, a consumer mental health advocacy organization, is in court today to defend its use and publication of a large set of internal Eli Lilly memos about Zyprexa, a newer antipsychotic medication.
The furor over the “smoking gun” Zyprexa memos began in early December 2006 when attorney Jim Gottstein made the memos available to a reporter from the New York Times, resulting three articles written about the unpublished risks associated with Zyprexa:
- 17 December 2006 — First article: Eli Lilly Said to Play Down Risk of Top Pill
- 18 December 2006 — Follow-up article the next day, on the front page: Drug Files Show Maker Promoted Unapproved Use
- 19 December 2006 — Editorial calling Eli Lilly to task, based on these revelations, Playing Down the Risks of a Drug
Eli Lilly sought and obtained the first court gag order on December 18 2006, requiring Jim Gottstein to cease and desist from disseminating any of the memos about Zyprexa from Eli Lilly. The court is also requiring Jim to save all copies of his email for possible examination by the courts.
The documents remain available from a Zyprexa wiki via a Tor share. Reportedly, attempts to actually download the Tor file have been unsuccessful (because the file is so large and Tor is a very slow way to disseminate such large files).
If you want more information about this unfolding story, please check out MindFreedom’s website.
Grohol, J. (2016). MindFreedom Battles Eli Lilly over Zyprexa Memos. Psych Central. Retrieved on January 21, 2017, from https://psychcentral.com/blog/archives/2007/01/03/mindfreedom-battles-eli-lilly-over-zyprexa-memos/